Taken together, we show that the impaired monocyte function induced by MG could be recapitulated in monocytes obtained from T2 diabetic human and db/db murine samples and SHP-2 inhibition ex vivo could reverse this monocyte dysfunction. This evidence concerns the gene PTPN11 and myasthenia gravis.